Abstract Details

Title Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Prophylactic Treatment Due to Compliance Issues

Topic Headache/Other Pain Syndromes

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Curt P. Schreiber, MD (CPS Medical Solutions)	Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Schreiber has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Schreiber has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for eisai. Dr. Schreiber has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for lilly. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for pfizer.
Shawn Love, MD (UCLA Ronald Reagan Medical Center)	No disclosure on file
	No disclosure on file

��ɫ��